Of the mutations that have been shown to be important in AML biology, of particular interest are mutations in TET2, IDH1, IDH2 and WT1, as they are known to influence both the epigenetic and transcriptomic landscape of AML [2]. This evidence concerns the gene IDH1 and acute myeloid leukemia.